Nuzenio

Phase Tipranks Tipranks

Phase Tipranks Tipranks news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 2 publisher sources 100/100 entity strength

Latest news

AbCellera to Report Phase 2 Menopause Therapy Data - tipranks.comtipranks.com · Sat, 08 Aug 2026 05:06:27 GMTAbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial - tipranks.comtipranks.com · Fri, 07 Aug 2026 17:02:38 GMTArtiva Therapeutics: Buy Rating Reiterated on Strong AlloNK RA Profile and Upcoming Phase III, Price Target Maintained at $41 - tipranks.comtipranks.com · Fri, 07 Aug 2026 10:59:49 GMTArtiva Therapeutics: Buy Rating Reiterated on Promising RA Data, Clear Phase 3 Path and Maintained $35 Price Target - tipranks.comtipranks.com · Fri, 07 Aug 2026 10:33:21 GMTAnalyst Reiterates Buy on Relay Therapeutics, Citing Lead Asset Zovegalisib’s Phase 3 Upside and Strong Cash Runway into 2029 - tipranks.comtipranks.com · Fri, 07 Aug 2026 09:43:38 GMTRLF AgTech bolsters board with top agribusiness leaders for next growth phase - tipranks.comtipranks.com · Thu, 06 Aug 2026 23:12:02 GMTBioVie says Phase 2 SUNRISE-PD trial of bezisterim met primary endpoint - tipranks.comtipranks.com · Thu, 06 Aug 2026 13:36:05 GMTAnalyst Reiterates Buy on EYPT Ahead of Pivotal LUGANO Phase III Data and Favorable Risk‑Reward Profile - tipranks.comtipranks.com · Thu, 06 Aug 2026 11:22:17 GMT

Timeline

Sat, 08 Aug 2026 05:06:27 GMTAbCellera to Report Phase 2 Menopause Therapy Data - tipranks.com
Fri, 07 Aug 2026 17:02:38 GMTAbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial - tipranks.com
Fri, 07 Aug 2026 10:59:49 GMTArtiva Therapeutics: Buy Rating Reiterated on Strong AlloNK RA Profile and Upcoming Phase III, Price Target Maintained at $41 - tipranks.com
Fri, 07 Aug 2026 10:33:21 GMTArtiva Therapeutics: Buy Rating Reiterated on Promising RA Data, Clear Phase 3 Path and Maintained $35 Price Target - tipranks.com
Fri, 07 Aug 2026 09:43:38 GMTAnalyst Reiterates Buy on Relay Therapeutics, Citing Lead Asset Zovegalisib’s Phase 3 Upside and Strong Cash Runway into 2029 - tipranks.com
Thu, 06 Aug 2026 23:12:02 GMTRLF AgTech bolsters board with top agribusiness leaders for next growth phase - tipranks.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phase Tipranks Tipranks.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.